glp-1 drugs what is it Patients' Use for Weight Loss, Benefit Gains GLP-1 Agonists: Using Semaglutide, Tirzepatide,

2023 Nov 28;13(1):20998

Patients taking semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks, with 86.4% achieving at least 5% weight loss and nearly half losing 15% or more

Obesity is a complex condition involving social, biological and psychosocial factors

You May Feel a Stronger Sense of Belonging Unfortunately, cultural stigma around obesity is still a very real problem

Effectiveness of GLP-1 Agonists The effectiveness of GLP-1 agonists in promoting weight loss has been well-documented through numerous clinical trials and research reviews

Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial